Cardiovascular patients

Sophia Papadakis, Andrew Pipe, Charalambos Vlachopoulos, Nikolaos Ioakeimidis, Pareskevi Katsaounou

Source: Eur Respir Monogr 2021; 90: 208-228
Disease area: Airway diseases

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sophia Papadakis, Andrew Pipe, Charalambos Vlachopoulos, Nikolaos Ioakeimidis, Pareskevi Katsaounou. Cardiovascular patients. Eur Respir Monogr 2021; 90: 208-228

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cardiovascular comorbidity and its impact on patients with COVID-19
Source: Eur Respir J, 55 (6) 2001227; 10.1183/13993003.01227-2020
Year: 2020



Cardiovascular assessment
Source: International Congress 2014 – PG13 Assessment of the obstructive sleep apnoea patient
Year: 2014




Cardiovascular comorbidity in severe COPD patients
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Cardiovascular diseases and COVID-19
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021

Cardiovascular disease in COPD
Source: Eur Respir Monogr 2020; 88: 47-65
Year: 2020


Late Breaking Abstract - Arterial Stiffness and Cardiovascular Risk in hospitalised COPD patients
Source: International Congress 2019 – Imaging of airway diseases
Year: 2019



Cardiovascular risk detection in COPD
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocol
Source: Eur Respir J 2013; 41: 1017-1022
Year: 2013



Cardiovascular complications and comorbidities in CAP
Source: Eur Respir Monogr 2014; 63: 256-254
Year: 2014

Cardiovascular morbidity in OSA
Source: Annual Congress 2003 - PG4 - Obstructive sleep apnoea - current pathophysiological, clinical and therapeutic concepts
Year: 2003

Cardiovascular limitation to exercise in COPD patients
Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing
Year: 2010

Cardiovascular disease in patients requiring NIV for ECOPD.
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019


Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk?
Source: Eur Respir J 2015; 46: 846-849
Year: 2015


Cardiovascular comorbidity in Danish patients with scleroderma-associated interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017


Cardiovascular status of patients with a severe form of COPD
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015


Late Breaking Abstract - Cardiovascular risk and COPD in a population-based study
Source: Virtual Congress 2021 – Asthma burden and management I
Year: 2021


Cardiovascular disease and complex OSA
Source: Annual Congress 2009 - PG21 Morbidity and mortality of sleep-disordered breathing: jointly organised with ACCP
Year: 2009